EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte Studie

The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma

Mees D Egeler, Sebastian Klobuch, Willemijn S Tak, Maartje W Rohaan, Troels H Borch, Inge M Noringriis, Renaud Tissier, Minke W Lucas, Winan van Houdt, Alexander C J van Akkooi, Inge Jedema, Marco Donia und 4 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115640 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Mees D Egeler und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosocial Oncology and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: m.egeler@nki.nl. Hauptthemen laut MEDLINE: Melanoma, Lymphocytes, Tumor-Infiltrating, Psychological Distress, Immunotherapy, Adoptive. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaLymphocytes, Tumor-InfiltratingPsychological DistressImmunotherapy, AdoptiveSkin NeoplasmsHumansMaleFemaleMiddle AgedAgedAdultTreatment OutcomeImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

Clinical outcomesEmotional distressImmunotherapyMelanomaSurvival

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Psychosocial Oncology and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: m.egeler@nki.nl.
  • Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands.
  • Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands; Netherlands Cancer Institute, Division of Radiotherapy, Amsterdam, the Netherlands.
  • National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Zitieren

APA

Egeler, M. D., Klobuch, S., Tak, W. S., Rohaan, M. W., Borch, T. H., Noringriis, I. M., Tissier, R., Lucas, M. W., van Houdt, W., van Akkooi, A. C. J., Jedema, I., Donia, M., Blank, C. U., Svane, I. M., Haanen, J. B. A. G., & van de Poll-Franse, L. V. (2025). The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115640

Vancouver

Egeler MD, Klobuch S, Tak WS, Rohaan MW, Borch TH, Noringriis IM, et al. The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115640

BibTeX
@article{Egeler2025,
  author = {Egeler, Mees D and Klobuch, Sebastian and Tak, Willemijn S and Rohaan, Maartje W and Borch, Troels H and Noringriis, Inge M and Tissier, Renaud and Lucas, Minke W and van Houdt, Winan and van Akkooi, Alexander C J and Jedema, Inge and Donia, Marco and Blank, Christian U and Svane, Inge Marie and Haanen, John B A G and van de Poll-Franse, Lonneke V},
  title = {The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanoma},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115640}
}
Kostenlos starten →